Physician profile
Danielle Harmon
NPI 1548791072
$4,980.97
in general payments reported to CMS, 2019-2025
10 companies · $899 in 2025
The $899 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $401 · 2022: $797 · 2023: $2,684 · 2024: $200 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,186 · Travel and Lodging: $1,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,186.42 |
| Travel and Lodging | $1,596.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,873.01 | 2021-2025 | Watchman Flx, Vigilant X4 Crt-D, Emblem Mri S-Icd |
| Biosense Webster, INC. | $1,351.59 | 2021-2025 | Carto 3, Qdot Micro, Qdot Micro Catheter |
| Janssen Pharmaceuticals, INC | $166.21 | 2021-2024 | Xarelto |
| Medtronic, INC. | $159.50 | 2021-2025 | Selectsecure, Endurant Iis |
| Novartis Pharmaceuticals Corporation | $134.96 | 2021-2024 | |
| Atricure, INC. | $110.08 | 2023-2024 | |
| Philips North America LLC | $90.86 | 2025 | Igt Devices Undivided |
| Pfizer INC. | $55.43 | 2023-2024 | |
| Kestra Medical Technology Services, INC. | $25.35 | 2025 | Assure Wcd |
| Abbott Laboratories | $13.98 | 2023 | Gallant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.